QurAlis NEWS

With a Strong Focus on ALS Patients, Mitsubishi Tanabe Pharma America Works to Increase Access and Foster Development With Quralis

June 1, 2018

Click here to go to the article.

Read More

Discovery Advances

May 22, 2018

We successfully generated a crystal structure of one of our early lead molecules in complex with our molecular target.  This structure is currently being used to design new compounds.

Read More

QurAlis Launches with Seed Funding from MPH, Amgen and Alexandria, united in the fight to cure ALS

April 5, 2018

CAMBRIDGE, Mass., April 5, 2018. QurAlis Corporation, a new private biotech company focused on developing precision solutions to cure ALS, today announced the addition of biotech investors MP Healthcare Venture…

Read More

QurAlis has won the Amgen Golden Ticket at LabCentral

December 15, 2017

CAMBRIDGE, Mass., Dec. 15, 2017  QurAlis was chosen by an Amgen internal committee and live audience members at a “Quick Pitch” event hosted by Amgen at its Cambridge R&D and Operations…

Read More

ALS News Today

JOIN US IN THE FIGHT AGAINST ALS

Whether you or a loved one is battling ALS and you want to be a part of our clinical trials, or you want to invest in the fight against this debilitating disease, we want to hear from you. Fill out the form below today and we will get back to you as quickly as possible.

  • This field is for validation purposes and should be left unchanged.